What is differentiation therapy?

Differentiation therapy is actually a misconception in this context. The correct term is targeted therapy, which is a more precise approach to cancer treatment. Targeted therapies, like Temozolomide (presumably what was meant by “Temoxegon”), are designed to attack specific molecular targets within cancer cells. This approach aims to maximize effectiveness while minimizing damage to healthy cells, reducing side effects compared to traditional chemotherapy. The goal is to provide more personalized and efficient treatment based on the cancer’s specific characteristics.